Mitochondrial ferritin attenuates β-amyloid-induced neurotoxicity: Reduction in oxidative damage through the Erk/P38 mitogen-activated protein kinase pathways

Antioxidants and Redox Signaling

Volumn 18, Issue 2, 2013, Pages 158-169

  Wu, Wen Shuang ^a   Zhao, Ya Shuo ^a   Shi, Zhen Hua ^a   Chang, Shi Yang ^a   Nie, Guang Jun ^b   Duan, Xiang Lin ^a   Zhao, Song Min ^a   Wu, Qiong ^a   Yang, Zhen Ling ^a   Zhao, Bao Lu ^c   Chang, Yan Zhong ^a  

^a HEBEI NORMAL UNIVERSITY   (China)

^b NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^c INSTITUTE OF BIOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; FERRITIN; MITOCHONDRIAL FERRITIN; MITOCHONDRIAL PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; CASPASE 3; CYTOCHROMES C; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FERRITINS; HIPPOCAMPUS; MALONDIALDEHYDE; MITOCHONDRIA; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING;

RATTUS;

EID: 84870481457     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4285     Document Type: Article

References (41)

1. Arosio P and Levi S. Ferritin, iron homeostasis, and oxida-tive damage. Free Radic Biol Med 33: 457-463, 2002.
2. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, and Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 130: 1910-1917, 1983.
3. Bush AI and Tanzi RE. Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics 5: 421-432, 2008.
4. Chang L and Karin M. Mammalian MAP kinase signalling cascades. Nature 410: 37-40, 2001.
5. Chen L, Liu L, Yin J, Luo Y, and Huang S. Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway. Int J Biochem Cell Biol 41: 1284-1295, 2009.
6. Chiu WT, Shen SC, Yang LY, Chow JM, Wu CY, and Chen YC. Inhibition of HSP90-dependent telomerase activity in amyloid beta-induced apoptosis of cerebral endothelial cells. J Cell Physiol 226: 2041-2051, 2011.
7. Chongthammakun V, Sanvarinda Y, and Chongthammakun S. Reactive oxygen species production and MAPK activation are implicated in tetrahydrobiopterin- induced SH-SY5Y cell death. Neurosci Lett 449: 178-182, 2009.
8. Eaton JW and Qian M. Molecular bases of cellular iron toxicity. Free Radic Biol Med 32: 833-840, 2002.
9. Goodsell DS. The molecular perspective: cytochrome C and apoptosis. Stem Cells 22: 428-429, 2004.
10. Hayashi T, Tsao LI, and Su TP. Antiapoptotic and cytotoxic properties of delta opioid peptide [D-Ala(2),D-Leu(5)]en-kephalin in PC12 cells. Synapse 43: 86-94, 2002.
11. Hsu MJ, Hsu CY, Chen BC, Chen MC, Ou G, and Lin CH. Apoptosis signal-regulating kinase 1 in amyloid beta pep-tide-induced cerebral endothelial cell apoptosis. J Neurosci 27: 5719-5729, 2007.
12. Keil U, Bonert A, Marques CA, Scherping I, Weyermann J, Strosznajder JB, Muller-Spahn F, Haass C, Czech C, Pradier L, Muller WE, and Eckert A. Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J Biol Chem 279: 50310-50320, 2004.
13. Kim TI, Lee YK, Park SG, Choi IS, Ban JO, Park HK, Nam SY, Yun YW, Han SB, Oh KW, and Hong JT. l-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxi-dative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways. Free Radic Biol Med 47: 1601-1610, 2009.
14. Langlois d'Estaintot B, Santambrogio P, Granier T, Gallois B, Chevalier JM, Precigoux G, Levi S, and Arosio P. Crystal structure and biochemical properties of the human mito-chondrial ferritin and its mutant Ser144Ala. J Mol Biol 340: 277-293, 2004.
15. Levi S, Corsi B, Bosisio M, Invernizzi R, Volz A, Sanford D, Arosio P, and Drysdale J. A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem 276: 24437-24440, 2001.
16. Mancuso C, Bates TE, Butterfield DA, Calafato S, Cornelius C, De Lorenzo A, Dinkova Kostova AT, and Calabrese V. Natural antioxidants in Alzheimer's disease. Expert Opin Investig Drugs 16: 1921-1931, 2007.
17. Mancuso C, Scapagini G, Curro D, Giuffrida Stella AM, De Marco C, Butterfield DA, and Calabrese V. Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front Biosci 12: 1107-1123, 2007.
18. Morimoto K, Yoshimi K, Tonohiro T, Yamada N, Oda T, and Kaneko I. Co-injection of beta-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons. Neu-roscience 84: 479-487, 1998.
19. Morisco C, Marrone C, Trimarco V, Crispo S, Monti MG, Sadoshima J, and Trimarco B. Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression. Cardiovasc Res 76: 453-464, 2007.
20. Morris CM, Kerwin JM, and Edwardson JA. Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus. Neurodegeneration 3: 267-275, 1994.
21. Nie G, Chen G, Sheftel AD, Pantopoulos K, and Ponka P. In vivo tumor growth is inhibited by cytosolic iron deprivation caused by the expression of mitochondrial ferritin. Blood 108: 2428-2434, 2006.
22. Nie G, Sheftel AD, Kim SF, and Ponka P. Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis. Blood 105: 2161-2167, 2005.
23. Rolston RK, Perry G, Zhu X, Castellani RJ, Dwyer BE, Lee HG, Petersen RB, and Smith MA. Iron: a pathological mediator of Alzheimer disease? Agro Food Ind Hi Tech 19: 33-36, 2009.
24. Selkoe DJ. Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 271: 18295-18298, 1996.
25. Selkoe DJ. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann N Y Acad Sci 924: 17-25, 2000.
26. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81: 741-766, 2001.
27. Shi ZH, Nie G, Duan XL, Rouault T, Wu WS, Ning B, Zhang N, Chang YZ, and Zhao BL. Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced do-paminergic cell damage: implication for neuroprotection in Parkinson's disease. Antioxid Redox Signal 13: 783-796, 2009.
28. Stepanichev MY, Onufriev MV, Yakovlev AA, Khrenov AI, Peregud DI, Vorontsova ON, Lazareva NA, and Gulyaeva NV. Amyloid-beta (25-35) increases activity of neuronal NO-synthase in rat brain. Neurochem Int 52: 1114-1124, 2008.
29. Stephan A and Phillips AG. A case for a non-transgenic animal model of Alzheimer's disease. Genes Brain Behav 4: 157-172, 2005.
30. Tamagno E, Parola M, Guglielmotto M, Santoro G, Bardini P, Marra L, Tabaton M, and Danni O. Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuro-nal apoptosis. Free Radic Biol Med 35: 45-58, 2003.
31. Tortosa A, Lopez E, and Ferrer I. Bcl-2 and Bax proteins in Lewy bodies from patients with Parkinson's disease and diffuse Lewy body disease. Neurosci Lett 238: 78-80, 1997.
32. Trubetskaya VV, Stepanichev MY, Onufriev MV, Lazareva NA, Markevich VA, and Gulyaeva NV. Administration of aggregated beta-amyloid peptide (25-35) induces changes in long-term potentiation in the hippocampus in vivo. Neurosci Behav Physiol 33: 95-98, 2003.
33. Umeda T, Tomiyama T, Sakama N, Tanaka S, Lambert MP, Klein WL, and Mori H. Intraneuronal amyloid beta oligo-mers cause cell death via endoplasmic reticulum stress, en-dosomal/lysosomal leakage, and mitochondrial dysfunction in vivo. J Neurosci Res 89: 1031-1042, 2011.
34. Wang L, Yang H, Zhao S, Sato H, Konishi Y, Beach TG, Abdelalim EM, Bisem NJ, and Tooyama I. Expression and localization of mitochondrial ferritin mRNA in Alzheimer's disease cerebral cortex. PLoS One 6: e22325, 2011.
35. Weis SN, Pettenuzzo LF, Krolow R, Valentim LM, Mota CS, Dalmaz C, Wyse AT, and Netto CA. Neonatal hypoxiaischemia induces sex-related changes in rat brain mitochondria. Mitochondrion 12: 271-279, 2011.
36. White FA, Keller-Peck CR, Knudson CM, Korsmeyer SJ, and Snider WD. Widespread elimination of naturally occurring neuronal death in Bax-deficient mice. J Neurosci 18: 1428-1439, 1998.
37. Yang ZH, Sun K, Suo WH, Yao LY, Fu Q, Cui YY, Fu GH, Chen HZ, and Lu Y. N-stearoyltyrosine protects primary neurons from Abeta-induced apoptosis through modulating mitogen-activated protein kinase activity. Neuroscience 169: 1840-1847, 2011.
38. Yankner BA, Duffy LK, and Kirschner DA. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250: 279-282, 1990.
39. Zecca L, Youdim MB, Riederer P, Connor JR, and Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5: 863-873, 2004.
40. Zhang R, Wang Z, Howson PA, Xia Z, Zhou S, Wu E, Xia Z, and Hu Y. Smilagenin attenuates beta amyloid (25-35)-induced degeneration of neuronal cells via stimulating the gene expression of brain-derived neurotrophic factor. Neu-roscience 210: 275-285, 2012.
41. Zhang Y and Zhao B. Green tea polyphenols enhance sodium nitroprusside-induced neurotoxicity in human neuro-blastoma SH-SY5Y cells. J Neurochem 86: 1189-1200, 2003.